Johnson & Johnson’s COVID-19 vaccine has received emergency use approval (EUA) in India, becoming the fifth vaccine to be approved after Oxford-AstraZeneca’s Covishield, Bharat Biotech’s Covaxin, Russia-made Sputnik V, and the United States’ Moderna.Side effects of Janssen’s COVID vaccine
Johnson & Johnson’s COVID-19 vaccine has received emergency use approval (EUA) in India, becoming the fifth vaccine to be approved after Oxford-AstraZeneca’s Covishield, Bharat Biotech’s Covaxin, Russia-made Sputnik V, and the United States’ Moderna.
